🟢 Cue Biopharma is trading 10% up today with XBI up 2.10%

Cue Biopharma is trading 10.04% up at $18.75 on October 21, 2026, amid biotech-sector strength; no company-specific catalyst is confirmed.

• The supplied sector context shows XBI up 2.10%.
• The latest surfaced company announcement was positive Phase 2 CUE-221 data on September 20, not a new October 21 update; it does not establish the reason for today’s move.